BI

BVF Inc Portfolio holdings

AUM $2.8B
1-Year Est. Return 17.96%
This Quarter Est. Return
1 Year Est. Return
+17.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$787M
AUM Growth
+$143M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$44.5M
2
+$20.2M
3
+$19.2M
4
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$18.9M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$15M

Top Sells

1
+$40.7M
2
+$20.7M
3
+$16M
4
OMED
OncoMed Pharmaceuticals, Inc.
OMED
+$14.7M
5
CYTK icon
Cytokinetics
CYTK
+$10.9M

Sector Composition

1 Healthcare 85.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$78.8M 10.01%
6,402,525
+342,900
2
$70.2M 8.92%
1,007,354
-584,292
3
$56.3M 7.16%
7,587,416
-661,000
4
$48.2M 6.13%
1,379,134
-280,066
5
$46.2M 5.88%
3,135,289
+1,278,394
6
$45.2M 5.74%
32,299
+2,597
7
$44.5M 5.65%
+3,367,080
8
$40.5M 5.15%
2,230,898
+203,900
9
$29.5M 3.75%
1,502,800
10
$29.1M 3.7%
43,326
+14,159
11
$27.4M 3.49%
8,596,357
12
$22M 2.79%
238,386
-225,000
13
$20.2M 2.57%
+1,353,846
14
– –
-4,400,289
15
$19.2M 2.44%
+1,000,000
16
$18M 2.29%
1,241,021
-749,300
17
$17.2M 2.19%
37,332
-6,317
18
$16.2M 2.06%
107,910
+80,586
19
$15M 1.91%
+950,000
20
$13.2M 1.68%
2,835
-576
21
$12.8M 1.63%
3,133,224
22
$11M 1.4%
163,169
+9,323
23
$10.6M 1.35%
3,588,830
+70,000
24
$10.5M 1.33%
7,866,108
25
$9.11M 1.16%
7,917
1
2